Scribd Logo
Upload

Welcome to Scribd!

  • 60 views

    PR - Teijin Pharma and SRETT Sign Exclusive Distribution Agreement For Respiratory Remote-Monitoring Device

    Uploaded by

    Yihui Flaux
    PR_Teijin Pharma and SRETT Sign Exclusive Distribution Agreement for Respiratory Remote-monitoring Device Improve todays's home oxygen therapy with remote patient monitoring by TeleOx.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    PR - Teijin Pharma and SRETT Sign Exclusive Distribution Agreement For Respiratory Remote-Monitoring Device

    Uploaded by

    Yihui Flaux
    60 views2 pages
    PR_Teijin Pharma and SRETT Sign Exclusive Distribution Agreement for Respiratory Remote-monitoring Device Improve todays's home oxygen therapy with remote patient monitoring by TeleOx.

    Original Title

    PR_Teijin Pharma and SRETT Sign Exclusive Distribution Agreement for Respiratory Remote-monitoring Device

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    PR_Teijin Pharma and SRETT Sign Exclusive Distribution Agreement for Respiratory Remote-monitoring Device Improve todays's home oxygen therapy with remote patient monitoring by TeleOx.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    60 views2 pages

    PR - Teijin Pharma and SRETT Sign Exclusive Distribution Agreement For Respiratory Remote-Monitoring Device

    Uploaded by

    Yihui Flaux
    PR_Teijin Pharma and SRETT Sign Exclusive Distribution Agreement for Respiratory Remote-monitoring Device Improve todays's home oxygen therapy with remote patient monitoring by TeleOx.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 2

    NEWS RELEASE

    Teijin Pharma and SRETT Sign Exclusive Distribution


    Agreement for Respiratory Remote-monitoring Device

    Tokyo, Japan, Oct 16, 2017 --- Teijin Pharma Limited, the core company of the Teijin
    Groups healthcare business, and SRETT, a French IoT provider, announced today they
    have agreed to an exclusive distribution arrangement in Japan for TeleOx, a device
    developed by SRETT which remotely monitors patients respiratory functions in
    oxygen therapy.

    TeleOx is a compact device with a diameter of 46mm and low weight of 34 grams,
    integrated with the oxygen cannula to measure patients respiratory rate and oxygen
    flow rate even during oxygen inhalation. TeleOx is Bluetooth Smart-enabled device
    and compatible with various systems, furthermore it can store the conditions of use for
    two years in built-in memories. This small device is compatible with Hi-Sanso3S,
    Hi-Sanso5S by Teijin Pharma, and will be launched in April 2018 in Japan. Teijin
    Pharma plans to provide rental service for medical institutions, aiming for leveraging
    TeleOx for patient instruction and management.

    TeleOx Image

    Since 1991, Teijin Pharma has been selling systems which monitor the operating status
    and oxygen flow settings of home oxygen concentrators and then providing this
    information to healthcare providers via telephone networks. However, since these
    systems do not monitor how much time patients have actually absorbed oxygen. Teijin
    Pharma acquired the exclusive distribution rights of TeleOx in Japan from SRETT with
    the aim of solving existing problems and promoting more appropriate use of home
    oxygen therapy by introducing TeleOx which can detect the situation of oxygen
    inhalation at home.

    Teijin Pharma will launch newly advanced oxygen-monitoring services incorporating


    TeleOx. The services are planned to be offered to medical institutions in April 2018.
    By developing next-generation services for home oxygen therapy, SRETT and Teijin
    Pharma look forward to contributing to improved home care in Japan.

    About SRETT
    Founded in 2004 in France, SRETT is an innovative IoT technology company which has
    become a leading provider of solutions for both industry and healthcare fields.

    In the past decade, SRETT has been committed to leveraging connected equipment so
    that professionals can preserve their resources and optimize their operations. The
    company has supplied over 200 000 connected objects in 17 countries, notably for oil &
    gas, tracking, and healthcare, and processes daily more than 5 million new individual
    pieces of data.

    SRETT is active in the field of homecare patient remote monitoring, for which it has
    developed a comprehensive range of solutions for chronic respiratory disease
    management. Already successful in Europe since 2012 in telemonitoring of CPAP
    therapy in sleep apnea patients, the company has engaged to offer new perspectives in
    treatment of COPD and comorbidities with easy to deploy IoT solutions.
    For more information, please visit www.srett.com

    About the Teijin Group


    Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the
    areas of environmental value; safety, security and disaster mitigation; and demographic
    change and increased health consciousness. Its main fields of operation are
    high-performance fibers such as aramid, carbon fibers & composites, healthcare, films,
    resin & plastic processing, polyester fibers, products converting and IT. The group has
    some 170 companies and around 19,000 employees spread out over 20 countries
    worldwide. It posted consolidated sales of JPY741.3 billion (USD 6.5 billion) and total
    assets of JPY 964.1 billion (USD 8.5 billion) in the fiscal year ending March 31, 2017.
    Please visit www.teijin.com

    Press Contact
    Corporate Communications
    Teijin Limited
    +81 3 3506 4055
    [email protected]

    You might also like